Related content

The Advantage of Alfacalcidol Over Vitamin D in the Treatment of Osteoporosis

By Shiraishi A.   Higashi S.   Ohkawa H.   Kubodera N.   Hirasawa T.   Ezawa I.   Ikeda K.   Ogata E.  

Calcified Tissue International, Vol. 65, Iss. 4, 1999-10 ,pp. : 311-316

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Glucocorticoid-Induced Osteoporosis with Alfacalcidol/Calcium Versus Vitamin D/Calcium

By Ringe J. D.   Cöster A.   Meng T.   Schacht E.   Umbach R.  

Calcified Tissue International, Vol. 65, Iss. 4, 1999-10 ,pp. : 337-340

Springer Publishing Company

Access to resources Recommend Favorite

Vitamin D Analogs: New Therapeutic Agents for Secondary Hyperparathyroidism

By Brown A.J.   Coyne D.W.  

Treatments in Endocrinology, Vol. 1, Iss. 5, 2002-01 ,pp. : 313-327

Adis International

Access to resources Recommend Favorite

Calcitriol-Resistant Rickets Due to Vitamin D Receptor Defects

By Hochberg Z.   Weisman Y.  

Trends in Endocrinology and Metabolism, Vol. 6, Iss. 6, 1995-08 ,pp. : 216-220

Elsevier

Access to resources Recommend Favorite

Randomized Trial of Alendronate Plus Vitamin D₃ Versus Standard Care in Osteoporotic Postmenopausal Women with Vitamin D Insufficiency

By Ralston Stuart   Binkley Neil   Boonen Steven   Kiel Douglas   Reginster Jean-Yves   Roux Christian   Chen Liang   Rosenberg Elizabeth   Santora Arthur  

Calcified Tissue International, Vol. 88, Iss. 6, 2011-06 ,pp. : 485-494

Springer Publishing Company

Access to resources Recommend Favorite